CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | Davis Hugh M. President and COO | Exercise or conversion | +18,675 | 45,425 | ||
| 2026-02-03 | Davis Hugh M. President and COO | Exercise or conversion · Restricted Stock Units | −18,675 | 56,025 | ||
| 2026-02-02 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +96,100 | 96,100 | ||
| 2026-02-02 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +336,300 | 336,300 | ||
| 2025-12-02 | Davis Hugh M. President and COO | Exercise or conversion | +26,750 | 26,750 | ||
| 2025-12-02 | Davis Hugh M. President and COO | Exercise or conversion · Restricted Stock Units | −26,750 | 80,250 | ||
| 2025-02-03 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +74,700 | 74,700 | ||
| 2025-02-03 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +261,600 | 261,600 | ||
| 2024-12-02 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2024-12-02 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +107,000 | 107,000 |
Page 1 of 1 · 10 trades